Our Portfolio

Deerfield portfolio companies strive to advance healthcare in meaningful and innovative ways.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Industry
Clear
Purpose of Financing
Clear
Stage
Clear
Structure of Financing
Clear
Status of Investment
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
:
Tag
Showing 0 of 100
Ascertain
Ascertain
Healthcare Services
Apr 2025
Venture
Early Stage
Equity
Current
Atlas Data Storage
Atlas Data Storage
Medical Technologies
May 2025
Venture
Seed/Startup
Equity
Current
Pipeline Health
Pipeline Health
Healthcare Services
Jan 2019
Growth
Mature
Debt and Equity
Current
Vanova Health
Vanova Health
Healthcare Services
May 2024
Growth
Seed/Startup
Equity
Current
LiquidXR
LiquidXR
Medical Technologies
Nov 2024
Venture
Seed/Startup
Debt and Equity
Current
Lumeris
Lumeris
Healthcare Services
Apr 2016
Growth
Late Stage
Debt and Equity
Current
Sequel Therapeutics
Sequel Therapeutics
Therapeutics
Nov 2018
Special Situations
Mature
Equity
Current
Neuroflow
Neuroflow
Healthcare Services
Current
Blink Health
Blink Health
Healthcare Services
Mar 2019
Growth
Growth
Equity
Current
Parabilis Medicines
Parabilis Medicines
Therapeutics
Oct 2016
Venture
Seed/Startup
Equity
Current
Conventus Flower Orthopedics
Conventus Flower Orthopedics
Medical Technologies
Nov 2014
Venture
Late Stage
Equity
Current
Concert
Concert
Healthcare Services
Dec 2017
Venture
Late Stage
Debt and Equity
Current
V-Wave
V-Wave
Medical Technologies
Apr 2018
Venture
Mid Stage
Equity
Current
Xeris Pharmaceuticals
Xeris Pharmaceuticals
Therapeutics
Dec 2015
Venture
Mid Stage
Equity
Current
Vesta Healthcare
Vesta Healthcare
Healthcare Services
Sep 2019
Venture
Early Stage
Equity
Current
DISCLAIMER

The portfolio companies shown represents a significant portion of the current portfolio of Deerfield funds utilizing the Private Design Strategy or Healthcare Innovations Strategy.  Exclusions include historical investments, research projects and related entities, companies in stealth mode, companies without material operations, companies in which Deerfield funds hold residual interests, investments in other funds, and investment portfolios of other Deerfield strategies. The specific portfolio companies identified are not representative of all of the portfolio companies purchased, sold, or recommended for Deerfield funds, and it should not be assumed that any investment in an identified portfolio company was or will be profitable. Actual holdings will vary for each Deerfield fund and there is no guarantee that a particular Deerfield fund will hold any or all of the portfolio companies listed.